COVID-19, Northwestern University and Moderna
Northwestern sues Moderna for patent infringement over COVID-19 vaccines
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax.
Moderna appropriated Northwestern research for COVID vaccine, lawsuit alleges
The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own researchers' technological breakthroughs.
Northwestern is suing one of the makers of the COVID-19 vaccines
The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been possible without research done in the Chicago area at Northwestern University.
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating GSK's patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax.
GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA.
Northwestern sues Moderna for alleged patent infringement in COVID shots
Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to combat the pandemic.
British drugmaker sues Moderna for patent infringement related to mRNA vaccines
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent rights in its mRNA technology used to develop its COVID-19 and RSV vaccines.
Impacts2h
How Moderna’s Success is Changing the Biotech Industry
In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
Medpage Today on MSN4d
Serena Williams' Surgery; Moderna Sued Over COVID Vax; Brighter Nights and Mortality
Retired tennis star Serena Williams said she underwent a procedure to remove a benign branchial cyst "the size of a small ...
Impacts1h
How Moderna is Changing the Biotech World
The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...
The Martha's Vineyard Times3d
COVID, flu vaccine clinic announced
The Vineyard boards of health are teaming up to bring vaccines back to the community at the end of the month. It’s not the ...
GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger ...
KOIN Portland on MSN11h
Is this year’s COVID booster a good match for new variants?
Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...
Is Moderna Inc. (MRNA) the Best QQQ Stock to Buy According to Analysts?
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...